Accueil > Newsroom > Page 2

Newsroom

news
All News Events Scientific papers
02.2015 The lancet
Safety, potential efficacy, and pharmacokinetics of specific polyclonal immunoglobulin F(ab’)₂ fragments against avian influenza A (H5N1) in healthy volunteers: a single-centre, randomised, double-blind, placebo-controlled, phase 1 study Scientific papers
07.2014 Future Medicine
Specific polyclonal F(ab’)2 neutralize a large panel of highly pathogenic avian influenza A viruses (H5N1) and control infection in mice Scientific papers
10.2012 Prod 1
Fabentech launches a phase I clinical trial in Singapore for its product against H5N1 avian influenza News